Voyager Therapeutics (VYGR) Operating Income Growth (5y) (2019 - 2026)
Voyager Therapeutics (VYGR) Operating Income Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,011.97 Bn | 67,011.68 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.88 Bn | 467.08 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.20 Bn | 114.96 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.17 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.85 Bn | 50.67 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Voyager Therapeutics | 181.76 Mn | 40.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.42% |
| Dec 31, 2025 | -4.75% |
| Sep 30, 2025 | -18.76% |
| Jun 30, 2025 | -32.46% |
| Mar 31, 2025 | -7.26% |
| Dec 31, 2024 | -22.71% |
| Sep 30, 2024 | 5.00% |
| Jun 30, 2024 | -29.45% |
| Mar 31, 2024 | 11.19% |
| Dec 31, 2023 | 34.09% |
| Sep 30, 2023 | -6.89% |
| Jun 30, 2023 | 0.21% |
| Mar 31, 2023 | 50.91% |
| Dec 31, 2022 | -14.75% |
| Sep 30, 2022 | 21.23% |
| Jun 30, 2022 | -0.77% |
| Mar 31, 2022 | -4.03% |
| Dec 31, 2021 | 19.25% |
| Sep 30, 2021 | -19.38% |
| Jun 30, 2021 | -24.34% |